Cargando…

Hospitalization Risks for Neurological Disorders in Primary Sjögren’s Syndrome Patients

Primary Sjögren’s syndrome (pSS) can be associated with neurological and cognitive involvement, negatively affecting patients’ quality of life. The aim of this study was to assess whether pSS patients are at higher risk of hospitalization for neurological diseases. Through a nationwide retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goulabchand, Radjiv, Gabelle, Audrey, Ayrignac, Xavier, Malafaye, Nicolas, Labauge, Pierre, Noël, Danièle, Morel, Jacques, Roubille, Camille, Barateau, Lucie, Guilpain, Philippe, Mura, Thibault
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000167/ https://www.ncbi.nlm.nih.gov/pubmed/35407586 http://dx.doi.org/10.3390/jcm11071979

Ejemplares similares

Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database
por: Goulabchand, Radjiv, et al.
Publicado: (2021)

Hospitalizations for infections in primary Sjögren’s syndrome patients: a nationwide incidence study : Severe infections in Sjögren’s syndrome
por: Goulabchand, Radjiv, et al.
Publicado: (2022)

The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients
por: Goulabchand, Radjiv, et al.
Publicado: (2022)

Two neurologic facets of CTLA4-related haploinsufficiency
por: Ayrignac, Xavier, et al.
Publicado: (2020)

Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
por: Maria, Alexandre Thibault Jacques, et al.
Publicado: (2019)

Identification of a Novel Serum Proteomic Signature for Primary Sjögren’s Syndrome
por: Padern, Guillaume, et al.
Publicado: (2021)

Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
por: Rozier, Pauline, et al.
Publicado: (2018)

Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players
por: Goulabchand, Radjiv, et al.
Publicado: (2020)

Patients’ Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study
por: Dumain, Cyril, et al.
Publicado: (2022)

Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature
por: Partouche, Léo, et al.
Publicado: (2020)

Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function
por: Fonteneau, Guillaume, et al.
Publicado: (2017)

Low Influenza, Pneumococcal and Diphtheria–Tetanus–Poliomyelitis Vaccine Coverage in Patients with Primary Sjögren’s Syndrome: A Cross-Sectional Study
por: Jacques, Morel, et al.
Publicado: (2019)

Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine, Endocrinology and Cardiology Units
por: Lohan, Laura, et al.
Publicado: (2021)

What if the worst consequences of COVID-19 concerned non-COVID patients?
por: Goulabchand, Radjiv, et al.
Publicado: (2020)

A Case Report of Solitary Sclerosis: This is Really Multiple Sclerosis
por: Lebrun, Christine, et al.
Publicado: (2017)

Digital tablets to improve quality of life of COVID-19 older inpatients during lockdown
por: Goulabchand, Radjiv, et al.
Publicado: (2020)

Neurological Disorders in Primary Sjögren's Syndrome
por: Tobón, Gabriel J., et al.
Publicado: (2012)

Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
por: Rozier, Pauline, et al.
Publicado: (2021)

Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond
por: Guilpain, Philippe, et al.
Publicado: (2021)

Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
por: Rozier, Pauline, et al.
Publicado: (2021)

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
por: Lehmann, Sylvain, et al.
Publicado: (2020)

Cranial nerve involvement in patients with MOG antibody–associated disease
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2019)

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2016)

Predicting dementia using socio-demographic characteristics and the Free and Cued Selective Reminding Test in the general population
por: Mura, Thibault, et al.
Publicado: (2017)

Neurological manifestations of primary Sjögren’s syndrome
por: Perzyńska-Mazan, Joanna, et al.
Publicado: (2018)

Neurological injury in primary Sjogren’s syndrome
por: Khalayli, Naram, et al.
Publicado: (2023)

Sjögren’s syndrome with and without neurological involvement
por: Seeliger, Tabea, et al.
Publicado: (2023)

Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies
por: Jentzer, Alexandre, et al.
Publicado: (2022)

Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion
por: Huby, Sophie, et al.
Publicado: (2023)

Neurological Involvement in Patients With Primary Sjögren’s Syndrome
por: Fan, Guihua, et al.
Publicado: (2021)

Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome
por: Sanosyan, Armen, et al.
Publicado: (2019)

Place of the (18)F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO)
por: Letertre, Simon, et al.
Publicado: (2021)

A rare initial neurological presentation of Sjogren's syndrome
por: Kumar, Srikanteswara Praveen
Publicado: (2015)

Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren’s Syndrome
por: Voigt, Alexandria, et al.
Publicado: (2014)

Clinical features and risk factors of neurological involvement in Sjögren’s syndrome
por: Ye, Wenjing, et al.
Publicado: (2018)

Fulminant Neurologic Manifestation of Sjogren’s Syndrome: A Case Report
por: Laxmidhar, Rosy M, et al.
Publicado: (2023)

Recent advances in treatment for narcolepsy
por: Barateau, Lucie, et al.
Publicado: (2019)

The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study
por: Villard, Orianne, et al.
Publicado: (2020)

iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
por: Maria, Alexandre T. J., et al.
Publicado: (2018)

Neurological and Inflammatory Manifestations in Sjögren’s Syndrome: The Role of the Kynurenine Metabolic Pathway
por: de Oliveira, Fabíola Reis, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dhbi3mlpk7tha0nnt1n43cb179